K-biotech innovation bears fruit in new drugs and treatments
Just one year into the Lee Jae-myung administration, South Korea's K-biotech industry has achieved historic milestones by successfully hitting two targets at once: regulatory innovation and expanding its global export footprint. Industry observers assess that by boldly overhauling long-standing regulations to reflect voices from the field, the sector has bui..